Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. (Q54376413)

29 May 2018

title

Maintenance of EGFR and EGFRvIII expressions in an in vivo and in vitro model of human glioblastoma multiforme. (English)

1 reference

29 May 2018

1 reference

Marie-Thérése Stockhausen

1

1 reference

29 May 2018

Helle Broholm

2

1 reference

29 May 2018

Mette Villingshøj

3

1 reference

29 May 2018

Maria Kirchhoff

4

1 reference

29 May 2018

Tommy Gerdes

5

1 reference

29 May 2018

Karina Kristoffersen

6

1 reference

29 May 2018

Michael Kosteljanetz

7

1 reference

29 May 2018

Mogens Spang-Thomsen

8

1 reference

29 May 2018

Hans Skovgaard Poulsen

9

1 reference

29 May 2018

language of work or name

English

0 references

publication date

15 April 2011

1 reference

29 May 2018

Experimental Cell Research

published in

1 reference

29 May 2018

volume

317

1 reference

29 May 2018

issue

11

1 reference

29 May 2018

page(s)

1513-1526

1 reference

29 May 2018

Genetic pathways to primary and secondary glioblastoma

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Overexpression of the EGF receptor and p53 mutations are mutually exclusive in the evolution of primary and secondary glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

A mutant epidermal growth factor receptor common in human glioma confers enhanced tumorigenicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

The enhanced tumorigenic activity of a mutant epidermal growth factor receptor common in human cancers is mediated by threshold levels of constitutive tyrosine phosphorylation and unattenuated signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Epidermal growth factor receptor mutation type III transfected into a small cell lung cancer cell line is predominantly localized at the cell surface and enhances the malignant phenotype

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Expression of a naturally occurring constitutively active variant of the epidermal growth factor receptor in mouse fibroblasts increases motility

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Resistance to tyrosine kinase inhibition by mutant epidermal growth factor receptor variant III contributes to the neoplastic phenotype of glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Differential response to gefitinib of cells expressing normal EGFR and the mutant EGFRvIII.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Constitutive EGFR signaling confers a motile phenotype to neural stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Mutant epidermal growth factor receptor displays increased signaling through the phosphatidylinositol-3 kinase/AKT pathway and promotes radioresistance in cells of astrocytic origin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

The tumor-specific de2-7 epidermal growth factor receptor (EGFR) promotes cells survival and heterodimerizes with the wild-type EGFR.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Clinical implications of the mechanism of epidermal growth factor receptor inhibitors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Epidermal growth factor receptor gene amplification and protein expression in glioblastoma multiforme: prognostic significance and relationship to other prognostic factors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Clinical significance of EGFR amplification and the aberrant EGFRvIII transcript in conventionally treated astrocytic gliomas.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

The natural history of EGFR and EGFRvIII in glioblastoma patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Prognostic effect of epidermal growth factor receptor and EGFRvIII in glioblastoma multiforme patients.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Prognostic impact of molecular markers in a series of 220 primary glioblastomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Epidermal growth factor receptor amplification does not have prognostic significance in patients with glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Immunohistochemical detection of EGFRvIII in high malignancy grade astrocytomas and evaluation of prognostic significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Molecular study of malignant gliomas treated with epidermal growth factor receptor inhibitors: tissue analysis from North American Brain Tumor Consortium Trials 01-03 and 00-01.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Molecular determinants of the response of glioblastomas to EGFR kinase inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Phase II trial of gefitinib in recurrent glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Contrasting in vivo and in vitro fates of glioblastoma cell subpopulations with amplified EGFR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Human cortical glial tumors contain neural stem-like cells expressing astroglial and neuronal markers in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Identification of human brain tumour initiating cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Isolation of cancer stem cells from adult glioblastoma multiforme

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Tumor stem cells derived from glioblastomas cultured in bFGF and EGF more closely mirror the phenotype and genotype of primary tumors than do serum-cultured cell lines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Quantitation and gompertzian analysis of tumor growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Automatic analysis of multiplex ligation-dependent probe amplification products (exemplified by a commercial kit for prenatal aneuploidy detection).

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Evaluation of epidermal growth factor receptor (EGFR) by chromogenic in situ hybridization (CISH) and immunohistochemistry (IHC) in archival gliomas using bright-field microscopy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Gene copy number for epidermal growth factor receptor (EGFR) and clinical response to antiEGFR treatment in colorectal cancer: a cohort study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Glioblastoma-derived stem cell-enriched cultures form distinct subgroups according to molecular and phenotypic criteria

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Subventricular zone astrocytes are neural stem cells in the adult mammalian brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Immunohistochemical analysis of the mutant epidermal growth factor, deltaEGFR, in glioblastoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Amplification and differential expression of members of the erbB-gene family in human glioblastoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Deletion and tandem duplication of exons 2 - 7 in the epidermal growth factor receptor gene of a human malignant glioma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Constitutive activation of phosphatidylinositol 3-kinase by a naturally occurring mutant epidermal growth factor receptor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Acquired rearrangement of an amplified epidermal growth factor receptor (EGFR) gene in a human glioblastoma xenograft

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Oncogenic epidermal growth factor receptor mutants with tandem duplication: gene structure and effects on receptor function.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Tandem duplication of the epidermal growth factor receptor tyrosine kinase and calcium internalization domains in A-172 glioma cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Amplified, overexpressed and rearranged epidermal growth factor receptor gene in a human astrocytoma cell line

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Isolation, Characterization, and use of Stem Cells from the CNS

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Stem cells in the central nervous system

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Localization of epidermal growth factor receptors and putative neuroblasts in human subependymal zone.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

A constitutively active epidermal growth factor receptor cooperates with disruption of G1 cell-cycle arrest pathways to induce glioma-like lesions in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

Activated EGFR signaling increases proliferation, survival, and migration and blocks neuronal differentiation in post-natal neural stem cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEXCR.2011.04.001

10.1016/J.YEXCR.2011.04.001

7 January 2021

Identifiers

DOI

1 reference

29 May 2018

1 reference

29 May 2018